Company intelligence
GlycanAge
Measure your real health. Predict your future health. Discover your bio-age with a test backed by 350+ research studies
About GlycanAge
At GlycanAge, we’re redefining the way we understand and measure aging. Backed by over 30 years of research and more than 300 peer-reviewed publications, our work centers on glycans—complex molecules that regulate inflammation and immune system function. These biomarkers offer a unique lens into your biological age, helping us understand how lifestyle, chronic inflammation, and environmental factors influence the aging process. Our flagship product, the GlycanAge® test, is a simple at-home test that goes beyond genetics to show how your body is actually aging—right now. It's already used by over 1,500 providers and tens of thousands of customers globally to track the impact of interventions and optimise preventative care strategies. Whether you're leading in the longevity space or taking the first step in your health journey, GlycanAge empowers you with actionable insights to live healthier for longer.
Verified activity
Signals from GlycanAge
16 published signals
Presence & Recognition
GlycanAge is hosting a live webinar on Thusday featuring Dr. Stephen Sideroff to discuss resilience and recovery.
Reported by GlycanAge
Research & Knowledge
GlycanAge tested testosterone therapy in men against IgG glycosylation and GlycanAge in the same research program, finding a clear shift toward a younger glycan profile with reduced agalactosylation and increased galactosylation and sialylation.
Reported by Gordan Lauc
Research & Knowledge
GlycanAge tested metformin in the same research program as testosterone therapy in men, finding that metformin showed no significant effect on glycosylation or GlycanAge in the vast majority of people tested.
Reported by Gordan Lauc
Research & Knowledge
GlycanAge published a study showing that estrogen decline during the menopause transition tracks closely with a sharp rise in pro-inflammatory glycan patterns, and hormone therapy reliably shifts that pattern back.
Reported by Nikolina Lauc
Research & Knowledge
GlycanAge published a study of over 1,900 women showing that glycan aging accelerates sharply during the transition from premenopause to postmenopause, faster than years before or after.
Reported by Gordan Lauc
Research & Knowledge
GlycanAge tracked Kate Rowe-Ham's perimenopause symptoms and found her GlycanAge result to be 51 years old at 44.
Reported by Nikolina Lauc
Research & Knowledge
GlycanAge tracked Kate Rowe-Ham's perimenopause symptoms and found her GlycanAge result to be 47 years old after six months of follow-up.
Reported by Nikolina Lauc
Research & Knowledge
GlycanAge published a study showing that testosterone improves IgG glycosylation in men through aromatization rather than testosterone itself.
Reported by Gordan Lauc
Products & Services
GlycanAge built its first product from a home-based team in the kitchen, starting with a black box for airplanes and a software company that employed women working from home.
Reported by Nikolina Lauc
Research & Knowledge
GlycanAge compared 17 different epigenetic clocks using blood samples collected at different points across the day to assess biological age from DNA methylation patterns.
Reported by Nikolina Lauc
Research & Knowledge
GlycanAge published a 2026 study finding that the therapeutic plasma exchange group had the largest monthly GlycanAge reduction among interventions included.
Reported by GlycanAge
Research & Knowledge
GlycanAge published a study comparing 38 adolescent ballet dancers to 77 non-dancer classmates of the same age, finding that girls who started intensive training earlier reached menarche significantly later and reported more irregular or absent cycles.
Reported by Nikolina Lauc
Research & Knowledge
GlycanAge is still working through which of the 47 connections between glycosylation and traits are meaningful versus coincidental.
Reported by Gordan Lauc
Research & Knowledge
GlycanAge identified 16 genes that control IgG glycosylation in a large genome-wide study.
Reported by Gordan Lauc
Research & Knowledge
GlycanAge researchers ran the same blood samples repeatedly using three plasma samples analyzed in quadruplicate over 26 days to track glycan traits and measure run-to-run variability.
Reported by Nikolina Lauc
Research & Knowledge
GlycanAge tested a glycan score built from five specific IgG markers against future type 2 diabetes risk in the EPIC-Potsdam cohort and checked it again in three independent validation studies.
Reported by Nikolina Lauc